Base Therapeutics (Shanghai) Co., Ltd.
Base Therapeutics (Shanghai) Co., Ltd.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, gastric neoplasm, intestinal disorder, neoplasm, rectal disorder, stomach disorder | Recruiting | Early phase 1 | 2026-10-01 | NCT07166263 | |
| NK521 in the Treatment of Advanced Solid Tumors | Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, hepatocellular carcinoma, liver disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Not yet recruiting | Early phase 1 | 2026-09-30 | NCT07657416 | |
| Safety and Efficacy of NK510 to Treat NSCLC | Neoplasms by Site, Pleural Effusion, Pleural Effusion, Malignant, Thoracic Neoplasms, neoplasm, non-small cell lung carcinoma, pleural disorder, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Early phase 1 | 2026-09-09 | NCT06097962 | |
| NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Early phase 1 | 2026-05-01 | NCT07561437 |